Le Lézard
Classified in: Health, Science and technology
Subjects: MISCELLANEOUS, MISCELLANEOUS

Renaissance BioScience and Certis Belchim enter partnership for innovative biopesticide development


Vancouver, Canada and Utrecht, Netherlands, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Renaissance BioScience, a leader in bioengineering microbes for the global agriculture and food industries, is pleased to announce that it has signed a joint development agreement (JDA) with Certis Belchim, a global leader in the development of crop-protecting biocontrol agents that combat agricultural pests. Under the JDA, the two industry leaders will collaboratively harness Renaissance's innovative yeast-based RNA interference (RNAi) platform technology to develop and commercialize an environmentally friendly biopesticide against an, as yet, unspecified target pest. This revolutionary technology holds immense promise for addressing agricultural challenges through its targeted approach. This partnership speaks to the companies' shared commitment to advancing eco-friendly alternatives in pest management.

Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented on the JDA: "Certis Belchim is a world leader in crop protection and biocontrol innovation and technologies, and we are delighted to be working with them to develop an effective and environmentally safe yeast-based RNAi biopesticide."

Mr. Jan Mostert, Head of Biorational Projects of Certis Belchim, commented: "Certis Belchim have committed and pursued innovative solutions for sustainable agriculture.   The Renaissance RNA interference technology is highly innovative and will deliver products which come close to the idea of an ideal plant protection product in being very specific and very effective at the same time while also reconciling the often-contradicting goals of crop protection, and protecting the environment and biodiversity. We believe this project could potentially contribute to reinforce our biorational platform, that is one of the strategic pillars for Certis Belchim. We are enthusiastic about working closely with Renaissance, a highly skilled and agile company, on this exciting biorational technology initiative."

About Certis Belchim BV
Certis Belchim, created through the merger of Certis Europe B.V. and Belchim Crop Protection NV/SA in 2022, provides a new force in crop protection. The company combines the strengths of these two well-established businesses with expertise in product development, registration and marketing and best-in-class technical and product knowledge. It has strong foundations and an established footprint throughout Europe, dynamic and growing platforms in North America and expanding opportunities with partners in Africa, South America and Asia. More information about Certis Belchim is available at www.certisbelchim.com.

About Renaissance BioScience Corp.
Based in Vancouver, Canada, Renaissance is a leading bioengineering company whose platform technologies are used to develop innovative, market-ready, functional microorganisms that provide cost-effective solutions to address a broad range of environmental, health and industrial efficiency challenges. Renaissance technologies create products for multiple end-use industries, including food & beverage, agriculture, animal and human health and energy. Detailed information about the Renaissance group of companies is available at www.renaissancebioscience.com.

###

For further information or to arrange interviews, please contact:

Steve Campbell
Campbell & Company Strategies Inc.
Communications and Public Relations
Vancouver, BC CANADA
01 604 888-5267
[email protected]

For commercial or technology development inquiries please contact:

Reesha Parmar
Manager of Business Development and Strategy
[email protected]



These press releases may also interest you

4 mar 2024
The Ibogaine By David Dardashti clinic is embarking on an ambitious initiative to advance knowledge and understanding of glial cells and their effect on the brain. Unlocking Brain Healing Ibogaine By David Dardashti hopes to advance...

4 mar 2024
The "Respiratory Syncytial Virus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering. The Global Respiratory Syncytial Virus (RSV) Diagnostics...

4 mar 2024
AnHeart Therapeutics ("AnHeart"), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...

4 mar 2024
The "Synthetic Hormones Market - A Global and Regional Analysis: Focus on Product Type, Route of Administration, Application, End User, and Region - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The...

4 mar 2024
As a chief physician at Anhui Provincial Hospital, Liu Lianxin has been advocating better medical and healthcare service system in China. Liu, also a member of the Chinese People's Political Consultative Conference (CPPCC), filed a proposal on...

4 mar 2024
The "Global Healthcare Cloud Computing Market by Offering (Solutions, Services), Business Model, Deployment Mode (Public Cloud, Hybrid Cloud, Private Cloud), End User (Healthcare Providers, Healthcare Payers), and Geography - Forecast to 2030" report...



News published on and distributed by: